Marshall Wace
GNLX icon

Marshall Wace’s Genelux GNLX Stock Holding History

Marshall Wace’s Portfolio GNLX Stock Details GNLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-139,148
Closed -$607K – 3399
2025
Q4 		$607K Buy
139,148
+105,402
+312% +$569K ﹤0.01% 2165
2025
Q3 		$142K Buy
33,746
+1,525
+5% +$5.42K ﹤0.01% 2616
2025
Q2 		$92.5K Buy
+32,221
New +$85.1K ﹤0.01% 2552
2025
Q1 		– Sell
-156,058
Closed -$368K – 2796
2024
Q4 		$368K Buy
156,058
+52,958
+51% +$141K ﹤0.01% 2165
2024
Q3 		$244K Buy
103,100
+93,100
+931% +$205K ﹤0.01% 2229
2024
Q2 		$19.5K Sell
10,000
-11,643
-54% -$39.6K ﹤0.01% 2471
2024
Q1 		$139K Buy
+21,643
New +$197K ﹤0.01% 2273

Other funds holding GNLX

WDC
Woodward Diversified Capital Bakersfield, California $220M AUM 30.39% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
FLPIM
F.L. Putnam Investment Management Lynnfield, Massachusetts $6.71B AUM 23.99% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Marshall Wace's GNLX Position: Q1 2026 in Review

Marshall Wace sold out of Genelux (GNLX) in Q1 2026, closing a stake of 139,148 shares — an estimated $607K sold.

Marshall Wace first reported a position in GNLX in Q1 2024 and held it in 7 quarters. The position peaked at $607K in Q4 2025. 71 funds tracked by Wall St. Rank hold GNLX as of Q1 2026.

  • Marshall Wace reported no remaining Genelux position as of Q1 2026 after selling out during the quarter.
  • Marshall Wace sold 139,148 Genelux shares in Q1 2026, an estimated $607K.
  • Marshall Wace first reported a position in Genelux in Q1 2024 and held it in 7 quarters.
  • Marshall Wace's Genelux position peaked at $607K in Q4 2025.
  • 71 funds tracked by Wall St. Rank held Genelux as of Q1 2026.

Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.